| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ironwood Pharmaceuticals Inc (IRWD) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. IRWD is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.90M | $7.01M | - | |
| VP | 658.0K | $2.43M | - | |
| Other | 500.5K | $1.85M | - | |
| Other | 416.6K | $1.54M | - | |
| Other | 350.4K | $1.29M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2018 | Consylman Gina | Chief Financial Officer | Sell | 3,594 | $14.66 | $52,688.04 | -2.0% | |
| Jan 24, 2018 | Currie Mark G53 | Chief Scientific Officer | Sale+OE | 60,000 | $15.45 | $927,000.00 | -7.2% | |
| Dec 7, 2017 | Hecht Peter M | Chief Executive Officer | Sale+OE | 113,405 | $15.12 | $1,714,515.00 | -1.2% | |
| Dec 4, 2017 | Olanoff Lawrence S | Director | Sell | 2,000 | $16.46 | $32,921.00 | -3.0% | |
| Dec 4, 2017 | McHugh Julie55 | Director | Sell | 1,500 | $16.45 | $24,675.00 | -1.9% | |
| Nov 10, 2017 | Consylman Gina | Interim CFO And CAO | Sell | 864 | $15.20 | $13,132.80 | -1.6% | |
| Sep 5, 2017 | Olanoff Lawrence S | Director | Sell | 2,000 | $16.15 | $32,300.00 | -5.7% | |
| Sep 5, 2017 | McHugh Julie55 | Director | Sell | 1,500 | $16.16 | $24,240.00 | -1.8% | |
| Aug 18, 2017 | Consylman Gina | Chief Accounting Officer | Sell | 207 | $14.34 | $2,968.38 | -0.4% | |
| Jun 22, 2017 | Gilbert Halley E | Chief Legal Officer | Sale+OE | 35,000 | $19.75 | $691,250.00 | -100% |